Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case–Control Study
Fei‐Yuan Hsiao(National Taiwan University), Churn‐Shiouh Gau(National Taiwan University), Pei-Hua Hsieh(National Taiwan University), Yi‐Wen Tsai(National Yang Ming Chiao Tung University), Weng-Foung Huang(National Yang Ming Chiao Tung University)
Cited by 67
Related Papers
Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study
|Canadian Medical Association Journal|2015|251
Using Taiwan's National Health Insurance research database for pharmacoepidemiology research
|Journal of Food and Drug Analysis|2020|126
A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 Consensus Update
|Nature Aging|2025|112
Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial
|The Lancet Healthy Longevity|2021|90